165 related articles for article (PubMed ID: 38325596)
21. MENX.
Pellegata NS
Ann Endocrinol (Paris); 2012 Apr; 73(2):65-70. PubMed ID: 22542001
[TBL] [Abstract][Full Text] [Related]
22. Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family.
Moers AM; Landsvater RM; Schaap C; Jansen-Schillhorn van Veen JM; de Valk IA; Blijham GH; Höppener JW; Vroom TM; van Amstel HK; Lips CJ
Am J Med; 1996 Dec; 101(6):635-41. PubMed ID: 9003111
[TBL] [Abstract][Full Text] [Related]
23. Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2.
Toledo SP; dos Santos MA; Toledo Rde A; Lourenço DM
Clinics (Sao Paulo); 2006 Feb; 61(1):59-70. PubMed ID: 16532227
[TBL] [Abstract][Full Text] [Related]
24. Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers.
Lebeault M; Pinson S; Guillaud-Bataille M; Gimenez-Roqueplo AP; Carrie A; Barbu V; Pigny P; Bezieau S; Rey JM; Delvincourt C; Giraud S; Veyrat-Durebex C; Saulnier P; Bouzamondo N; Chabbert M; Blin J; Mohamed A; Romanet P; Borson-Chazot F; Rohmer V; Barlier A; Mirebeau-Prunier D
Thyroid; 2017 Dec; 27(12):1511-1522. PubMed ID: 28946813
[TBL] [Abstract][Full Text] [Related]
25. Multiple endocrine neoplasia type 2A due to an exon 8 (G533C) mutation in a large North American kindred.
Castro MR; Thomas BC; Richards ML; Zhang J; Morris JC
Thyroid; 2013 Dec; 23(12):1547-52. PubMed ID: 23461807
[TBL] [Abstract][Full Text] [Related]
26. Animal models of multiple endocrine neoplasia.
Wiedemann T; Pellegata NS
Mol Cell Endocrinol; 2016 Feb; 421():49-59. PubMed ID: 26184857
[TBL] [Abstract][Full Text] [Related]
27. [Polyadenomatoses: type 2 multiple endocrine neoplasms].
Conte-Devolx B; Niccoli-Sire P;
Presse Med; 2002 Aug; 31(26):1224-30. PubMed ID: 12212516
[TBL] [Abstract][Full Text] [Related]
28. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C
Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251
[TBL] [Abstract][Full Text] [Related]
29. [Multiple endocrine neoplasia syndromes. Type 2].
Juodele L; Juozaityte E; Zindzius A; Pundzius J
Medicina (Kaunas); 2005; 41(4):281-94. PubMed ID: 15864001
[TBL] [Abstract][Full Text] [Related]
30. Multiple endocrine neoplasms.
Falchetti A; Marini F; Luzi E; Tonelli F; Brandi ML
Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):149-63. PubMed ID: 18328987
[TBL] [Abstract][Full Text] [Related]
31. Multiple endocrine neoplasia type 2.
Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Tognarini I; Luzi E; Brandi ML
Orphanet J Rare Dis; 2006 Nov; 1():45. PubMed ID: 17105651
[TBL] [Abstract][Full Text] [Related]
32. Clinical features and signaling effects of RET D631Y variant multiple endocrine neoplasia type 2 (MEN2).
Lee JY; Kim SY; Jo KH; Mo EY; Kim ES; Kim HS; Han JH; Moon SD
Korean J Intern Med; 2022 Mar; 37(2):398-410. PubMed ID: 34905813
[TBL] [Abstract][Full Text] [Related]
33. Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms.
Guerin C; Romanet P; Taieb D; Brue T; Lacroix A; Sebag F; Barlier A; Castinetti F
Endocr Relat Cancer; 2018 Feb; 25(2):T15-T28. PubMed ID: 28874394
[TBL] [Abstract][Full Text] [Related]
34. Solid tumors associated with multiple endocrine neoplasias.
Almeida MQ; Stratakis CA
Cancer Genet Cytogenet; 2010 Nov; 203(1):30-6. PubMed ID: 20951316
[TBL] [Abstract][Full Text] [Related]
35. Multiple endocrine neoplasia syndromes associated with mutation of p27.
Lee M; Pellegata NS
J Endocrinol Invest; 2013 Oct; 36(9):781-7. PubMed ID: 23800691
[TBL] [Abstract][Full Text] [Related]
36. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
37. [Multiple endocrine neoplasia type 2].
Niccoli-Sire P; Conte-Devolx B
Ann Endocrinol (Paris); 2007 Oct; 68(5):317-24. PubMed ID: 17626779
[TBL] [Abstract][Full Text] [Related]
38. Multiple endocrine neoplasia type 2.
Lodish M
Front Horm Res; 2013; 41():16-29. PubMed ID: 23652668
[TBL] [Abstract][Full Text] [Related]
39. Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management.
Raue F; Frank-Raue K
Hormones (Athens); 2009; 8(1):23-8. PubMed ID: 19269918
[TBL] [Abstract][Full Text] [Related]
40. Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome.
Ruggeri RM; Benevento E; De Cicco F; Grossrubatscher EM; Hasballa I; Tarsitano MG; Centello R; Isidori AM; Colao A; Pellegata NS; Faggiano A
Endocrine; 2023 Dec; 82(3):480-490. PubMed ID: 37632635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
